Webinars, Pharmaceutical

Aptar Pharma discusses intranasal administration for CNS therapeutics

CNS therapies are a well-defined target for drug repurposing for intranasal administration with a growing track record of success that includes commercialized products for treatment resistant depression and seizures.

This webinar examines the defining benefits of intranasal administration such as high patient acceptability, rapid onset, and the ability to deliver drugs to unconscious patients. The biology of drug delivery for CNS therapeutics is also explored with reference to the benefits of bypassing the blood brain barrier. Off-the-shelf devices for intranasal administration are reviewed and strategies for reformulation – powder or liquid – are considered.

The expert support available from Aptar Pharma, to support all aspects of drug reformulation for intranasal administration, are also discussed.

Watch the webinar
Speaker(s): Dr. Julie D. Suman
25 Feb 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

27 Mar 2023

Delivery of Biologics to the Nasal Cavity: The Future of Nasal Drug Delivery

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
13 Mar 2023

Moving Towards Greater Recyclability in Drug Delivery – Sustainable Solutions b...

Webinars, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
13 Mar 2023

Nasal Delivery of Biologics: A Whole New Ball Game

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
5 Jan 2023

Case Study – Unidose Nasal Spray Pump for Epilepsy

Case Studies, Pharmaceutical, Product Solutions, Device Innovations, Market Insights

Read More
1 2 3 19

Request Access


Requesting access to Aptar Pharma discusses intranasal administration for CNS therapeutics.

  • This field is for validation purposes and should be left unchanged.
Back To Top